GB9611603D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB9611603D0
GB9611603D0 GBGB9611603.3A GB9611603A GB9611603D0 GB 9611603 D0 GB9611603 D0 GB 9611603D0 GB 9611603 A GB9611603 A GB 9611603A GB 9611603 D0 GB9611603 D0 GB 9611603D0
Authority
GB
United Kingdom
Prior art keywords
stands
alkyl radical
aryl
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9611603.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEUTICAL PROD Ltd
Leo Pharma AS
Original Assignee
PHARMACEUTICAL PROD Ltd
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEUTICAL PROD Ltd, Leo Pharmaceutical Products Ltd AS filed Critical PHARMACEUTICAL PROD Ltd
Priority to GBGB9611603.3A priority Critical patent/GB9611603D0/en
Publication of GB9611603D0 publication Critical patent/GB9611603D0/en
Priority to RO98-01607A priority patent/RO120133B1/ro
Priority to AU30256/97A priority patent/AU714223B2/en
Priority to PT97924929T priority patent/PT906276E/pt
Priority to CZ0397198A priority patent/CZ296255B6/cs
Priority to ES97924929T priority patent/ES2179343T3/es
Priority to HK99104930.7A priority patent/HK1019733B/xx
Priority to CA 2254806 priority patent/CA2254806A1/en
Priority to DE69714590T priority patent/DE69714590T2/de
Priority to EP97924929A priority patent/EP0906276B1/en
Priority to JP10500106A priority patent/JP2000511894A/ja
Priority to PCT/DK1997/000225 priority patent/WO1997046522A1/en
Priority to DK97924929T priority patent/DK0906276T3/da
Priority to AT97924929T priority patent/ATE221875T1/de
Priority to CN971950202A priority patent/CN1217926C/zh
Priority to RU98121401/04A priority patent/RU2165413C2/ru
Priority to PL97329941A priority patent/PL186804B1/pl
Priority to US09/202,200 priority patent/US6197982B1/en
Priority to NZ332237A priority patent/NZ332237A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
GBGB9611603.3A 1996-06-04 1996-06-04 Chemical compounds Pending GB9611603D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB9611603.3A GB9611603D0 (en) 1996-06-04 1996-06-04 Chemical compounds
NZ332237A NZ332237A (en) 1996-06-04 1997-05-15 Vitamin D analogues
DE69714590T DE69714590T2 (de) 1996-06-04 1997-05-15 Vitamin d analoge verbindungen
JP10500106A JP2000511894A (ja) 1996-06-04 1997-05-15 新規ビタミンｄ類似体
PT97924929T PT906276E (pt) 1996-06-04 1997-05-15 Novos analogos da vitamina d
CZ0397198A CZ296255B6 (cs) 1996-06-04 1997-05-15 Analog vitaminu D, zpusob jeho výroby a pouzití afarmaceutická kompozice s jeho obsahem
ES97924929T ES2179343T3 (es) 1996-06-04 1997-05-15 Nuevos analogos de la vitamina d.
HK99104930.7A HK1019733B (en) 1996-06-04 1997-05-15 Novel vitamin d analogues
CA 2254806 CA2254806A1 (en) 1996-06-04 1997-05-15 Novel vitamin d analogues
RO98-01607A RO120133B1 (ro) 1996-06-04 1997-05-15 Derivaţi analogi ai vitaminei d
EP97924929A EP0906276B1 (en) 1996-06-04 1997-05-15 Novel vitamin d analogues
AU30256/97A AU714223B2 (en) 1996-06-04 1997-05-15 Novel vitamin D analogues
PCT/DK1997/000225 WO1997046522A1 (en) 1996-06-04 1997-05-15 Novel vitamin d analogues
DK97924929T DK0906276T3 (da) 1996-06-04 1997-05-15 Nye vitamin D analoger
AT97924929T ATE221875T1 (de) 1996-06-04 1997-05-15 Vitamin d analoge verbindungen
CN971950202A CN1217926C (zh) 1996-06-04 1997-05-15 新的维生素d类似物
RU98121401/04A RU2165413C2 (ru) 1996-06-04 1997-05-15 Аналоги витамина d, способ их получения, фармацевтическая композиция
PL97329941A PL186804B1 (pl) 1996-06-04 1997-05-15 Nowy 20-epi analog witaminy D, sposób wytwarzania20-epi analogu witaminy D, kompozycja farmaceutyczna i zastosowanie 20-epi analogu witaminy D
US09/202,200 US6197982B1 (en) 1996-06-04 1997-05-15 Vitamin D analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9611603.3A GB9611603D0 (en) 1996-06-04 1996-06-04 Chemical compounds

Publications (1)

Publication Number Publication Date
GB9611603D0 true GB9611603D0 (en) 1996-08-07

Family

ID=10794707

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9611603.3A Pending GB9611603D0 (en) 1996-06-04 1996-06-04 Chemical compounds

Country Status (17)

Country Link
US (1) US6197982B1 (enExample)
EP (1) EP0906276B1 (enExample)
JP (1) JP2000511894A (enExample)
CN (1) CN1217926C (enExample)
AT (1) ATE221875T1 (enExample)
AU (1) AU714223B2 (enExample)
CZ (1) CZ296255B6 (enExample)
DE (1) DE69714590T2 (enExample)
DK (1) DK0906276T3 (enExample)
ES (1) ES2179343T3 (enExample)
GB (1) GB9611603D0 (enExample)
NZ (1) NZ332237A (enExample)
PL (1) PL186804B1 (enExample)
PT (1) PT906276E (enExample)
RO (1) RO120133B1 (enExample)
RU (1) RU2165413C2 (enExample)
WO (1) WO1997046522A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
EP1458678A1 (en) * 2002-11-18 2004-09-22 Teva Pharmaceutical Industries Limited A crystallization method for purification of calcipotriene
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
KR20110113664A (ko) * 2006-08-29 2011-10-17 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
AU2010208323B2 (en) 2009-01-27 2016-03-10 Berg Llc Vitamin D3 and analogs thereof for alleviating side effects associated with chemotherapy
EP2464357B1 (en) 2009-08-14 2019-05-22 Berg LLC Vitamin d3 and analogs thereof for treating alopecia
US20120322776A1 (en) * 2009-12-22 2012-12-20 Leo Pharma A/S Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants
CN102770121B (zh) * 2009-12-22 2014-10-15 利奥制药有限公司 包含溶剂混合物和维生素d衍生物或类似物的药物组合物
PT2360145E (pt) * 2010-01-26 2012-06-27 Hybrigenics Sa Novo processo para isomerização de estruturas bicíclicas condensadas e preparação de análogos de vitamina d que as contêm
HUE025554T2 (en) * 2010-10-25 2016-02-29 Teijin Pharma Ltd Vitamin D3-23-in derivative
SG10201709894RA (en) 2013-05-29 2018-01-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
AU2016234990B2 (en) 2015-10-02 2018-12-06 Lg Electronics Inc. Washing machine and method for controlling the same
AU2016234988B2 (en) 2015-10-02 2018-08-02 Lg Electronics Inc. Washing machine
US20170096769A1 (en) 2015-10-02 2017-04-06 Lg Electronics Inc. Method for controlling washing machine
US12351551B2 (en) * 2019-11-27 2025-07-08 Yonsung Fine Chemical Co., Ltd. Method for producing maxacalcitol, and intermediate therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU688125A3 (ru) * 1974-12-09 1979-09-25 Тейдзин Лимитед (Фирма) Способ получени 1 , 24/ /диокси-холекальциферола или 1 , 24 / /-диоксихолекальциферола или их производных
EP0296800B1 (en) 1987-06-23 1991-10-16 Yamanouchi Pharmaceutical Co. Ltd. Vitamin d3 derivatives
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9223061D0 (en) 1992-11-04 1992-12-16 Leo Pharm Prod Ltd Chemical compounds
US5552392A (en) 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds

Also Published As

Publication number Publication date
EP0906276B1 (en) 2002-08-07
PL329941A1 (en) 1999-04-26
RU2165413C2 (ru) 2001-04-20
CN1217926C (zh) 2005-09-07
RO120133B1 (ro) 2005-09-30
EP0906276A1 (en) 1999-04-07
WO1997046522A1 (en) 1997-12-11
DE69714590T2 (de) 2003-04-24
AU714223B2 (en) 1999-12-23
CZ296255B6 (cs) 2006-02-15
AU3025697A (en) 1998-01-05
ES2179343T3 (es) 2003-01-16
ATE221875T1 (de) 2002-08-15
CZ397198A3 (cs) 1999-03-17
JP2000511894A (ja) 2000-09-12
DE69714590D1 (de) 2002-09-12
PL186804B1 (pl) 2004-02-27
CN1219928A (zh) 1999-06-16
DK0906276T3 (da) 2002-12-02
HK1019733A1 (en) 2000-02-25
PT906276E (pt) 2002-12-31
NZ332237A (en) 2000-07-28
US6197982B1 (en) 2001-03-06

Similar Documents

Publication Publication Date Title
PL329941A1 (en) Novel analoques of vitamin d
EP0703902A4 (enExample)
GB9206648D0 (en) Chemical compounds
GB9214202D0 (en) Chemical compounds
ES8303411A1 (es) Un procedimiento para la preparacion de derivados de tiofilina o teobromina.
ATE165346T1 (de) Neue vitamin d-derivate
GR880100208A (en) Preparation method of new aminotetrahydro-5,6,7,8,naphtho (2,3b) furane
GB9622590D0 (en) Chemical compounds
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
MX9505054A (es) Derivados de ester de bisfenol.
TW238304B (en) A process for the preparation of 1-substituted-5(4H)-tetrazolinones
GB9524812D0 (en) Chemical compounds
EP0390305A3 (en) Diester and keto-ester derivatives of polyhydroxy compounds and production thereof
FI810145L (fi) Nya substituerade 1,8-dihydroxi-9-(10h)antracenoner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
EP0546875A3 (en) New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof